Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative

Código QR

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative

María Julieta Russo,1 Gabriela Cohen,1 Patricio Chrem Mendez,1 Jorge Campos,1 Federico E Nahas,1 Ezequiel I Surace,1 Silvia Vazquez,1 Deborah Gustafson,2,3 Salvador Guinjoan,1 Ricardo F Allegri,1 Gustavo Sevlever1 On behalf of the Argentina-Alzheimer’s Disease Neuroima...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Russo MJ, Cohen G, Chrem Mendez P, Campos J, Nahas FE, Surace EI, Vazquez S, Gustafson D, Guinjoan S, Allegri RF, Sevlever G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Aging Alzheimer´s disease amyloid imaging biomarkers mild cognitive impairment. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f58febdda9c24447a2255881639ce4bd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
por: Harris P, et al.
Publicado: (2015)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang N, et al.
Publicado: (2018)

Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
por: Donoso,Archibaldo, et al.
Publicado: (2001)

Biomarkers in Alzheimer’s disease
por: Janeiro Manuel H., et al.
Publicado: (2020)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)

Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review
por: Ticinesi A, et al.
Publicado: (2018)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
por: Wang J, et al.
Publicado: (2020)

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease
por: Fulop T, et al.
Publicado: (2021)

From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution
por: Cheng YW, et al.
Publicado: (2017)

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease
por: Huang L, et al.
Publicado: (2018)

Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience
por: Ding B, et al.
Publicado: (2014)

Mild cognitive impairment and its management in older people
por: Eshkoor SA, et al.
Publicado: (2015)

The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer’s Disease: A Review
por: Megan Rose Readman, et al.
Publicado: (2021)

Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
por: Archibaldo Donoso,S, et al.
Publicado: (2009)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
por: Celina S. Liu, et al.
Publicado: (2021)

Contextual Processing and the Impacts of Aging and Neurodegeneration: A Scoping Review
por: Tran KH, et al.
Publicado: (2021)

Repetitive Transcranial Magnetic Stimulation Improves Mild Cognitive Impairment Associated with Alzheimer’s Disease in Mice by Modulating the miR-567/NEUROD2/PSD95 Axis
por: Pang Y, et al.
Publicado: (2021)

Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease
por: Yuan Sh, et al.
Publicado: (2021)

Effect of Memo®, a natural formula combination, on Mini-Mental State Examination scores in patients with mild cognitive impairment
por: Yakoot M, et al.
Publicado: (2013)

Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s disease
por: Zhang YY, et al.
Publicado: (2013)

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease
por: Choe YM, et al.
Publicado: (2018)

What Are the Key Points of Treatment for Cases of Mild Cognitive Impairment? Based on the Evaluation of Cognitive Function Tasks in the ADASJcog
por: Yoshihiko Yoshii, et al.
Publicado: (2021)

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner M, et al.
Publicado: (2019)

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?
por: Chung JY, et al.
Publicado: (2019)

Effects of Meditation on Structural Changes of the Brain in Patients With Mild Cognitive Impairment or Alzheimer’s Disease Dementia
por: Madhukar Dwivedi, et al.
Publicado: (2021)

Spatial Navigation and Visuospatial Strategies in Typical and Atypical Aging
por: Martina Laczó, et al.
Publicado: (2021)

Large-Scale Functional Networks, Cognition and Brain Structures Supporting Social Cognition and Theory of Mind Performance in Prodromal to Mild Alzheimer’s Disease
por: Jose Manuel Valera-Bermejo, et al.
Publicado: (2021)

Regional Neural Activity Changes in Parkinson’s Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients
por: Xing Y, et al.
Publicado: (2021)

Vitamin D and neurocognitive function
por: Schlögl M, et al.
Publicado: (2014)

The Influence of MTHFR Polymorphism on Gray Matter Volume in Patients With Amnestic Mild Cognitive Impairment
por: Mengzhe You, et al.
Publicado: (2021)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Chieh-Hsin Lin, et al.
Publicado: (2021)

Agregados amiloides: rol en desórdenes de conformación proteica
por: Duran-Aniotz,Claudia, et al.
Publicado: (2013)

Alzheimer’s disease and language impairments: social intervention and medical treatment
por: Klimova B, et al.
Publicado: (2015)

Diffusion Tensor Imaging Study of Olfactory Identification Deficit in Patients With Mild Cognitive Impairment
por: Yongjia Shao, et al.
Publicado: (2021)

Thiamine deficiency contributes to synapse and neural circuit defects
por: Yu,Qiujian, et al.
Publicado: (2018)

Hindi Version of Addenbrooke’s Cognitive Examination III: Distinguishing Cognitive Impairment Among Older Indians at the Lower Cut-Offs
por: Bajpai S, et al.
Publicado: (2020)

Effects of creative expression therapy for older adults with mild cognitive impairment at risk of Alzheimer’s disease: a randomized controlled clinical trial
por: Zhao J, et al.
Publicado: (2018)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
por: Shima Mehrabadi, et al.
Publicado: (2021)

Alzheimer disease: 100 years later
por: Puglielli MD,Luigi, et al.
Publicado: (2001)